Dual infection with Mycobacterium tuberculosis and Pneumocystis jiroveci Lymphadenitis in a Patient with HIV infection: case report and review of the literature.
We report a case of dual Mycobacterium tuberculosis (TB) and Pneumocystis jiroveci (carinii) (PCP) lymphadenitis in a patient with HIV who had been receiving trimethoprim-sulfamethoxazole (TMP-SMX) as systemic prophylaxis for PCP. This patient was successfully treated with antituberculosis medications and TMP-SMX. Our review of the literature identified this as the first reported case of dual TB and PCP lymphadenitis in an HIV-infected host and highlights the potential limitations of TMP-SMX prophylaxis.
Khawcharoenporn
Thana
T
Department of Medicine, Thammasart University Hospital, Pratumthani, Thailand.
Apisarnthanarak
Anucha
A
Sakonlaya
Dussadee
D
Mundy
Linda M
LM
Bailey
Thomas C
TC
D000328:Adult; D019072:Antibiotic Prophylaxis; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008199:Lymphadenitis / Q000150:complications* / Q000382:microbiology; D009169:Mycobacterium tuberculosis; D016720:Pneumocystis Infections / Q000150:complications* / Q000382:microbiology; D045363:Pneumocystis carinii; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D014388:Tuberculosis, Lymph Node / Q000150:complications* / Q000382:microbiology
D015662:Trimethoprim, Sulfamethoxazole Drug Combination